Clinical Pharmacology of Novel Selective COX-2 Inhibitors

Article OPEN
Tacconelli, S.; Capone, M.; Patrignani, P.;

Novel coxibs (i.e. etoricoxib, valdecoxib, parecoxib and lumiracoxib) with enhanced biochemical cyclooxygenase (COX)-2 selectivity over that of rofecoxib and celecoxib have been recently developed. They have the potential advantage to spare COX-1 activity, thus reducing... View more
Share - Bookmark

  • Download from
    ZENODO via ZENODO (Article, 2004)
  • Cite this publication